(NYT) – People over 65 represent prime targets for such medications. “The prevalence of obesity hovers around 40 percent” in older adults, as measured by body mass index, said Dr. John Batsis, a geriatrician and obesity specialist at the University of North Carolina School of Medicine.

The proportion of people with Type 2 diabetes rises with age, too, to nearly 30 percent over age 65. Yet a recent JAMA Cardiology study found that among Americans over 65 with diabetes, about 60 percent discontinued semaglutide within a year. (Read More)